Global Payments Valuation
Is GPN * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GPN * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GPN * (MX$2130) is trading above our estimate of fair value (MX$1860.38)
Significantly Below Fair Value: GPN * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GPN *?
Other financial metrics that can be useful for relative valuation.
What is GPN *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$27.84b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.6x |
Enterprise Value/EBITDA | 10.9x |
PEG Ratio | 1.9x |
Price to Earnings Ratio vs Peers
How does GPN *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 41.4x | ||
FIS Fidelity National Information Services | 77.5x | 26.2% | US$37.7b |
CPAY Corpay | 21.9x | 13.5% | US$21.3b |
ADYEN Adyen | 50.2x | 19.3% | €35.0b |
PYPL PayPal Holdings | 16.1x | 4.1% | US$69.2b |
GPN * Global Payments | 21.5x | 11.6% | Mex$27.8b |
Price-To-Earnings vs Peers: GPN * is good value based on its Price-To-Earnings Ratio (21.5x) compared to the peer average (41.4x).
Price to Earnings Ratio vs Industry
How does GPN *'s PE Ratio compare vs other companies in the South American Diversified Financial Industry?
Price-To-Earnings vs Industry: GPN * is expensive based on its Price-To-Earnings Ratio (21.5x) compared to the South American Diversified Financial industry average (8.9x).
Price to Earnings Ratio vs Fair Ratio
What is GPN *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 21.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GPN *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$2,535.40 0% | 13.7% | Mex$3,454.56 | Mex$1,524.07 | n/a | 35 |
Apr ’25 | Mex$2,215.03 | Mex$2,590.34 +16.9% | 12.5% | Mex$3,379.08 | Mex$1,490.77 | n/a | 35 |
Mar ’25 | n/a | Mex$2,689.68 0% | 12.1% | Mex$3,492.07 | Mex$1,540.62 | n/a | 35 |
Feb ’25 | n/a | Mex$2,565.52 0% | 12.8% | Mex$3,102.50 | Mex$1,551.25 | n/a | 35 |
Jan ’25 | n/a | Mex$2,436.94 0% | 13.7% | Mex$3,057.95 | Mex$1,528.97 | n/a | 35 |
Dec ’24 | n/a | Mex$2,443.29 0% | 14.5% | Mex$3,079.40 | Mex$1,539.70 | n/a | 35 |
Nov ’24 | n/a | Mex$2,556.59 0% | 13.9% | Mex$3,206.21 | Mex$1,692.17 | n/a | 34 |
Oct ’24 | n/a | Mex$2,511.50 0% | 15.1% | Mex$3,602.49 | Mex$1,656.12 | n/a | 30 |
Sep ’24 | Mex$2,139.91 | Mex$2,515.63 +17.6% | 14.6% | Mex$3,606.26 | Mex$1,657.86 | n/a | 32 |
Aug ’24 | n/a | Mex$2,376.39 0% | 16.8% | Mex$3,507.15 | Mex$1,635.55 | n/a | 32 |
Jul ’24 | n/a | Mex$2,361.88 0% | 18.3% | Mex$3,563.16 | Mex$1,524.62 | n/a | 32 |
Jun ’24 | n/a | Mex$2,434.19 0% | 17.3% | Mex$3,656.10 | Mex$1,564.39 | n/a | 31 |
May ’24 | n/a | Mex$2,505.88 0% | 16.8% | Mex$3,729.15 | Mex$1,595.65 | Mex$2,130.00 | 30 |
Apr ’24 | n/a | Mex$2,550.57 0% | 17.8% | Mex$3,748.66 | Mex$1,603.99 | Mex$2,215.03 | 27 |
Mar ’24 | n/a | Mex$2,693.00 0% | 18.3% | Mex$3,829.26 | Mex$1,638.48 | n/a | 25 |
Feb ’24 | Mex$2,152.46 | Mex$2,709.10 +25.9% | 20.7% | Mex$4,132.52 | Mex$1,671.79 | n/a | 27 |
Jan ’24 | n/a | Mex$2,876.41 0% | 18.1% | Mex$4,259.75 | Mex$2,187.96 | n/a | 27 |
Dec ’23 | n/a | Mex$2,956.24 0% | 17.6% | Mex$4,335.43 | Mex$2,187.07 | n/a | 27 |
Nov ’23 | Mex$2,466.24 | Mex$3,039.79 +23.3% | 16.7% | Mex$4,417.26 | Mex$2,267.79 | n/a | 27 |
Oct ’23 | n/a | Mex$3,371.17 0% | 15.7% | Mex$4,841.57 | Mex$2,662.86 | n/a | 27 |
Sep ’23 | Mex$2,522.00 | Mex$3,417.21 +35.5% | 15.0% | Mex$4,861.37 | Mex$2,673.75 | Mex$2,139.91 | 27 |
Aug ’23 | n/a | Mex$3,460.65 0% | 15.3% | Mex$4,889.74 | Mex$2,505.99 | n/a | 28 |
Jul ’23 | n/a | Mex$3,504.78 0% | 14.7% | Mex$4,825.78 | Mex$2,473.21 | n/a | 33 |
Jun ’23 | Mex$2,419.99 | Mex$3,541.50 +46.3% | 13.1% | Mex$4,788.10 | Mex$2,832.96 | n/a | 33 |
May ’23 | n/a | Mex$3,737.24 0% | 11.5% | Mex$4,860.62 | Mex$2,875.87 | n/a | 32 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.